Arthritis/rheumatic disorders:

Indications for RIDAURA:

Active rheumatoid arthritis unresponsive to NSAIDs.


Initially 6mg daily in 1–2 divided doses. If response inadequate after 6 months, may increase to 3mg 3 times daily. If still ineffective after 3 months, discontinue.


Not recommended.


History of gold-induced disorders.

Boxed Warning:

Gold toxicity. Physicians should be experienced in chrysotherapy.


Be fully familiar with chrysotherapy and this product's toxicity and benefits before use. Impaired renal or hepatic function. Inflammatory bowel disease. Rash. History of bone marrow depression. Monitor CBC with differential, platelet count, urinalysis, renal, liver function and for GI bleeding. Discontinue immediately if thrombocytopenia, proteinuria, or hematuria occurs. Pregnancy (Cat.C), nursing mothers: not recommended.

Pharmacologic Class:

DMARD (gold salt).

Adverse Reactions:

Bone marrow depression, proteinuria, hematuria, diarrhea, GI upset, ulcerative colitis, rash, pruritus, exfoliative dermatitis, stomatitis, conjunctivitis, proteinuria, nephrotic syndrome, cholestatic jaundice, gold bronchitis, pneumonitis, peripheral neuropathy.

How Supplied:


Pricing for RIDAURA

3mg capsule (Qty: 60)
Appx. price $1349